The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Direct Transcriptional Up-regulation of Cyclooxygenase-2 by Hypoxia-Inducible Factor (HIF)-1 Promotes Colorectal Tumor Cell Survival and Enhances HIF-1 Transcriptional Activity during Hypoxia
Abstract
Cyclooxygenase (COX)-2, the inducible key enzyme for prostanoid biosynthesis, is overexpressed in most colorectal carcinomas and a subset of colorectal adenomas. Genetic, biochemical, and clinical evidence indicates an important role for COX-2 in colorectal tumorigenesis. Although COX-2 can be induced by aberrant growth factor signaling and oncogene activation during colorectal tumorigenesis, the role of microenvironmental factors such as hypoxia in COX-2 regulation remains to be elucidated. For the first time, we report that under hypoxic conditions COX-2 protein levels increase in colorectal adenoma and carcinoma cells. Rigorous analyses reveal that COX-2 up-regulation is transcriptional and is associated with hypoxia-inducible factor (HIF)-1alpha induction. Oligonucleotide pull-down and chromatin immunoprecipitation assays reveal that HIF-1alpha binds a hypoxia-responsive element on the COX-2 promoter. COX-2 up-regulation during hypoxia is accompanied by increased levels of prostaglandin E(2) (PGE(2)), which promote tumor cell survival under hypoxic conditions. In addition, elevated levels of PGE(2) in hypoxic colorectal tumor cells enhance vascular endothelial growth factor expression and HIF-1 transcriptional activity by activating the mitogen-activated protein kinase pathway, showing a potential positive feedback loop that contributes to COX-2 up-regulation during hypoxia. This study identifies COX-2 as a direct target for HIF-1 in colorectal tumor cells. In addition, COX-2 up-regulation represents a pivotal cellular adaptive response to hypoxia with implication for colorectal tumor cell survival and angiogenesis. We propose that using modified COX-2-selective inhibitors, which are only activated under hypoxic conditions, could potentially be a novel more selective strategy for colorectal cancer prevention and treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, hypoxia also induces COX-2 [86].”
From The Pathogenesis of Adenomyosis vis-à-vis Endometriosis (2020) · cites this paper as [86]
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E. T., Gordon, G., Wakabayashi, N., Saunders, B. P., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,522
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
Eberhart, C. E., Coffey, R. J., Aramandla, R., Giardiello, F. M., Ferrenbach, S., & DuBois, R. N. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90246-1 · Cited by 2,512
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Research works printed but not linked: 1
- Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in Apc δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803–9. · DOI
Cited by
Sorted by citations
Items 101–200 of 301
Protein Kinase CK2 in Cancer Energetics
Silva-Pavez, E., & Tapia, J. C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00893 · Cited by 54
Rani, S., Roy, S., Singh, M., & Kaithwas, G. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2407223 · Cited by 57
Reactive oxygen species in tendon injury and repair
Kračun, D., Görlach, A., Snedeker, J. G., & Buschmann, J. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103568 · Cited by 54
Knieß, T., Laube, M., Bergmann, R., Sehn, F., Graf, F., Steinbach, J., Wuest, F. R., & Pietzsch, J. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.04.022 · Cited by 53
Moore, A. E., Greenhough, A., Roberts, H. R., Hicks, D. J., Patsos, H. A., Williams, A. C., & Paraskeva, C. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp183 · Cited by 53
Four types of fatty acids exert differential impact on pancreatic cancer growth
Yu, M., Liu, H., Duan, Y., Zhang, D., Li, S., & Wang, F. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.002 · Cited by 51
Smartt, H. J. M., Greenhough, A., Ordóñez‐Morán, P., Talero, E., Cherry, C. A., Wallam, C. A., Parry, L., Kharusi, M. A., Roberts, H. R., Mariadason, J. M., et al. (2011) · Gut · doi:10.1136/gutjnl-2011-300817 · Cited by 51
Zhang, Q., Han, X., Chen, J., Xie, X., Xu, J., Zhao, Y., Shen, J., Hu, L. T., Xu, P., Song, H., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004251 · Cited by 54
Sánchez‐Alonso, S., Alcaraz‐Serna, A., Sánchez‐Madrid, F., & Alfranca, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02799 · Cited by 54
Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy
Buqué, A., Bloy, N., Aranda, F., Cremer, I., Eggermont, A. M. M., Fridman, W. H., Fucikova, J. P., Galon, J., Špíšek, R., Tartour, É., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1149674 · Cited by 50
Hypoxia Induces Macrophage tnfa Expression via Cyclooxygenase and Prostaglandin E2 in vivo
Lewis, A., & Elks, P. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02321 · Cited by 49
Wang, F., Liu, S., Xi, S., Yan, L., Wang, H. H., Song, Y., & Sun, G. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.08.008 · Cited by 49
Bielefeldt‐Ohmann, H., Tolnay, A.-E., Reisenhauer, C., Hansen, T. R., Smirnova, N. P., & Campen, H. V. (2008) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2007.10.006 · Cited by 49
Genetic deletion of COX-2 diminishes VEGF production in mouse retinal Müller cells
Yanni, S. E., McCollum, G. W., & Penn, J. S. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.03.019 · Cited by 49
TRAIL-Mediated Apoptosis in Breast Cancer Cells Cultured as 3D Spheroids
Chandrasekaran, S., Marshall, J. R., Messing, J., Hsu, J., & King, M. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111487 · Cited by 50
Roberts, H. R., Smartt, H. J. M., Greenhough, A., Moore, A. E., Williams, A. C., & Paraskeva, C. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr210 · Cited by 48
Angiogenic signaling aberrantly induced by tumor hypoxia
Takenaga, K. (2010) · Frontiers in bioscience · doi:10.2741/3674 · Cited by 47
Sellam, L.-S., Zappasodi, R., Chettibi, F., Djennaoui, D., mesbah, N. Y. A., Amir, Z.-C., Touil–Boukoffa, C., Ouahioune, W., Merghoub, T., & Bourouba, M. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108479 · Cited by 48
Valadkhan, S., & Valencia-Hipólito, A. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_489 · Cited by 49
The role of hypoxia in oral cancer and potentially malignant disorders: a review
Kujan, O., Shearston, K., & Farah, C. S. (2016) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12488 · Cited by 48
Wu, J., Xiao, K., Fu, W., Gao, X., Zhang, H., Wang, W., Ma, N., Zhao, M., Hao, X., & Zhang, Z. (2016) · Molecules · doi:10.3390/molecules21121756 · Cited by 47
Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs
Batalla, I. B., Cubas‐Cordova, M., Udonta, F., Wroblewski, M., Waizenegger, J. S., Janning, M., Sawall, S., Gensch, V., Zhao, L., Martínez-Zubiaurre, I., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3437 · Cited by 47
Functional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunity
Göbel, C., Breitenbuecher, F., Kalkavan, H., Hähnel, P. S., Kasper, S., Hoffarth, S., Merches, K., Schild, H., Lang, K. S., & Schüler, M. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.531 · Cited by 50
Wollenick, K., Hu, J. J., Kristiansen, G., Schraml, P., Rehrauer, H., Berchner‐Pfannschmidt, U., Fandrey, J., Wenger, R. H., & Stiehl, D. P. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr978 · Cited by 53
Campillo, N., Torres, M., Vilaseca, A., Nonaka, P. N., Gozal, D., Roca‐Ferrer, J., Picado, C., Montserrat, J. M., Farré, R., Navajas, D., et al. (2017) · Scientific Reports · doi:10.1038/srep44693 · Cited by 50
Grimmer, C., Pfander, D., Swoboda, B., Aigner, T. G., Mueller, L., Hennig, F. F., & Gelse, K. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23136 · Cited by 45
Activation of HIF-1α does not increase intestinal tumorigenesis
Xue, X., Ramakrishnan, S. K., & Shah, Y. M. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00112.2014 · Cited by 46
Daneau, G., Boidot, R., Martinive, P., & Féron, O. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0583 · Cited by 44
Wei, L., Zhou, Y., Yao, J., Qiao, C., Ni, T., Guo, R., Guo, Q., & Lu, N. (2015) · Oncotarget · doi:10.18632/oncotarget.3838 · Cited by 42
Greenhough, A., Wallam, C. A., Hicks, D. J., Moorghen, M., Williams, A. C., & Paraskeva, C. (2010) · Oncogene · doi:10.1038/onc.2010.94 · Cited by 43
Sansone, P., Piazzi, G., Paterini, P., Strillacci, A., Ceccarelli, C., Minni, F., Biasco, G., Chieco, P., & Bonafè, M. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00580.x · Cited by 43
The Role of Inflammatory Mediators in Colorectal Cancer Hepatic Metastasis
Goodla, L., & Xue, X. (2022) · Cells · doi:10.3390/cells11152313 · Cited by 44
Pathological functions of hypoxia in endometriosis
Hsiao, K.-Y. (2015) · Frontiers in Bioscience · doi:10.2741/e736 · Cited by 61
HIF-1 is the Commander of Gateways to Cancer
Ma, N. (2011) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000054 · Cited by 40
The Adaptive Complexity of Cancer
Derbal, Y. (2018) · BioMed Research International · doi:10.1155/2018/5837235 · Cited by 41
Poudyal, D., Le, P. M., Davis, T., Hofseth, A. B., Chumanevich, A. P., Chumanevich, A. A., Wargovich, M. J., Nagarkatti, M., Nagarkatti, P. S., Windust, A. J., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0421 · Cited by 39
Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis
Rohwer, N., Jumpertz, S., Erdem, M., Egners, A., Warzecha, K. T., Fragoulis, A., Kühl, A. A., Kramann, R., Neuß, S., Rudolph, I., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0816-4 · Cited by 37
Lee, Y., Guo, H.-C., Zhao, G.-H., Yang, C., Chang, H.-Y., Yang, R., Chen, L., & Lee, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104581 · Cited by 38
He, S., Lu, G., Hou, H., Zhao, Z., Zhu, Z., Lu, X., Chen, J., & Wang, Z. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2574 · Cited by 38
Ravizza, R., Molteni, R., Gariboldi, M. B., Marras, E., Perletti, G., & Monti, E. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.12.021 · Cited by 38
Guo, C., Wu, M., Guo, Z., Zhang, R., Wang, Z., Peng, X., Dong, J., Sun, X., Zhang, Z., Xiao, P., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c07183 · Cited by 38
Modulating T regulatory cells in cancer: how close are we?
Banerjee, A., Vasanthakumar, A., & Grigoriadis, G. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.12 · Cited by 38
Angelucci, A., Monache, S. D., Cortellini, A., Padova, M. D., & Ficorella, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010299 · Cited by 40
Aspirin inhibits hypoxia-mediated lung cancer cell stemness and exosome function
Chen, J., Xu, R., Xia, J., Huang, J., Su, B., & Wang, S. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.03.008 · Cited by 38
Bocca, C., Bozzo, F., Cannito, S., Parola, M., & Miglietta, A. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20846 · Cited by 37
Kundu, J. K., & Surh, Y. (2009) · Phytochemistry Reviews · doi:10.1007/s11101-009-9132-x · Cited by 36
Pang, L., Cai, Y., Tang, E. H. C., Irwin, M. G., Ma, H., & Xia, Z. (2016) · Journal of Diabetes Research · doi:10.1155/2016/1324347 · Cited by 36
Petrangeli, E., Coroniti, G., Brini, A. T., de Girolamo, L., Stanco, D., Niada, S., Silecchia, G., Morgante, E., Lubrano, C., Russo, M. A., et al. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25113 · Cited by 36
Ling, C., Xie, Y., Zhao, D., Zhu, Y., Xiang, J., & Yang, J. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.50 · Cited by 35
Cuomo, F., Coppola, A., Botti, C., Maione, C., Forte, A., Scisciola, L., Liguori, G., Caiafa, I., Ursini, M. V., Galderisi, U., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24221-5 · Cited by 35
COX-2 Signaling in the Tumor Microenvironment
Zhang, Y., Tighe, S. P., & Zhu, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-50224-9_6 · Cited by 36
Inhibition of osteoclastogenesis by prolyl hydroxylase inhibitor dimethyloxallyl glycine
Leger, A. J., Altobelli, A., Mosquea, L. M., Belanger, A. J., Song, A., Cheng, S. H., Jiang, C., & Yew, N. S. (2010) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-010-0171-6 · Cited by 35
Chun, K., Kim, E., Kim, D., Song, N., Kim, W., Na, H., & Surh, Y. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116259 · Cited by 38
Srivastava, A., Banerjee, J., Dubey, V., Tripathi, M., Chandra, P. S., Sharma, M. C., Lalwani, S., Siraj, F., Doddamani, R. S., & Dixit, A. B. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00994-0 · Cited by 36
Studies of postpartum mammary gland involution reveal novel pro-metastatic mechanisms
Wallace, T. R., Tarullo, S. E., Crump, L. S., & Lyons, T. R. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2019.01 · Cited by 31
Methyl syringate, a TRPA1 agonist represses hypoxia-induced cyclooxygenase-2 in lung cancer cells
Park, J., Shim, M. K., Jin, M., Rhyu, M., & Lee, Y. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.01.009 · Cited by 33
HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling
Xue, X., Jungles, K. N., Onder, G., Samhoun, J., Győrffy, B., & Hardiman, K. M. (2016) · Oncotarget · doi:10.18632/oncotarget.7272 · Cited by 33
Cytokines and pregnancy: Potential regulation by histone deacetylases
Munro, S. K., Balakrishnan, B., Lissaman, A. C., Gujral, P., & Ponnampalam, A. P. (2021) · Molecular Reproduction and Development · doi:10.1002/mrd.23430 · Cited by 35
Lodi, A., Tiziani, S., Khanim, F. L., Drayson, M. T., Günther, U. L., Bunce, C. M., & Viant, M. R. (2010) · ACS Chemical Biology · doi:10.1021/cb900300j · Cited by 31
RNAi-Based Strategies for Cyclooxygenase-2 Inhibition in Cancer
Strillacci, A., Griffoni, C., Valerii, M. C., Lazzarini, G., Tomasi, V., & Spisni, E. (2010) · BioMed Research International · doi:10.1155/2010/828045 · Cited by 31
Detecting Disease Specific Pathway Substructures through an Integrated Systems Biology Approach
Alaimo, S., Marceca, G. P., Ferro, A., & Pulvirenti, A. (2017) · Non-Coding RNA · doi:10.3390/ncrna3020020 · Cited by 29
Wang, L., Wu, H., Xiong, L., Liu, X., Yang, N., Luo, L., Qin, T., Zhu, X., Shen, Z., Hua, J., et al. (2020) · BioMed Research International · doi:10.1155/2020/9485398 · Cited by 30
Non-histone substrates of histone deacetylases as potential therapeutic targets in epilepsy
Kumar, S., Attrish, D., Srivastava, A., Banerjee, J., Tripathi, M., Chandra, P. S., & Dixit, A. B. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1860016 · Cited by 30
Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
DiGiacomo, J. W., & Gilkes, D. M. (2018) · Targeted Oncology · doi:10.1007/s11523-018-0555-4 · Cited by 29
Song, H., Park, J., Choi, K., Lee, J., Chen, J., Park, H., Yu, B.-I., Iida, M., Rhyu, M., & Lee, Y. (2018) · Journal of Ginseng Research · doi:10.1016/j.jgr.2018.11.007 · Cited by 29
Stöhr, D., Jeltsch, A., & Rehm, M. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.02.002 · Cited by 32
Ren, Y., Tian, Y., Mao, X., Wen, H., Qi, X., Li, J., Li, J., & Li, Y. (2022) · Frontiers in Marine Science · doi:10.3389/fmars.2022.1024218 · Cited by 27
Targeting COX-2/PGE2 Pathway in HIPK2 Knockdown Cancer Cells: Impact on Dendritic Cell Maturation
Garufi, A., Pistritto, G., Ceci, C., Renzo, L. D., Santarelli, R., Faggioni, A., Cirone, M., & D’Orazi, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048342 · Cited by 29
Epithelial–mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib
Kirane, A., Toombs, J. E., Larsen, J. E., Ostapoff, K. T., Meshaw, K. R., Zaknoen, S. L., Brekken, R. A., & Burrows, F. J. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs195 · Cited by 28
Benzothiazole derivatives in the design of antitumor agents
Paoletti, N., & Supuran, C. T. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202400259 · Cited by 27
Hypoxia regulates inflammatory gene expression in endothelial cells
Flamant, L., Toffoli, S., Raes, M. J., & Michiels, C. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.11.020 · Cited by 27
Fan, C., Han, J., Liu, X., Zhang, F., Long, Y., & Xie, Q. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519001363 · Cited by 27
Rytkönen, K. T., Renshaw, G. M. C., Vainio, P. P., Ashton, K. J., Williams-Pritchard, G., Leder, E. H., & Nikinmaa, M. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00081.2012 · Cited by 27
Ruiz‐Heiland, G., Yong, J., von Bremen, J., & Ruf, S. (2020) · Clinical Oral Investigations · doi:10.1007/s00784-020-03501-3 · Cited by 26
Wang, C.-C., Wang, Y., Yu, N.-Q., Hu, D., Wang, X., Chen, X., Liao, Y.-W., Yao, J., Wang, H., He, L., et al. (2017) · Molecules · doi:10.3390/molecules22050732 · Cited by 26
Schoos, A., Gabriel, C., Knab, V. M., & Fux, D. A. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.257501 · Cited by 24
Li, P., Lü, J., Kaur, C., Sivakumar, V., Tan, K. L., & Ling, E. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.044 · Cited by 25
Chang, K.-Y., Shen, M.-R., Lee, M.-Y., Wang, W.-L., Su, W., Chang, W., & Chen, B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806210200 · Cited by 25
Chen, W., Hung, W., Kang, W.-Y., Huang, Y., SU, Y., Yang, C.-H., & Chai, C. (2009) · Apmis · doi:10.1111/j.1600-0463.2008.00004.x · Cited by 25
Hollyer, T. R., Bordoni, L., Kousholt, B. S., van Luijk, J. A. K. R., Ritskes-Hoitinga, M. J., & Østergaard, L. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14633 · Cited by 25
Sha, W., Olesch, C., Hanaka, H., Rådmark, O., Weigert, A., & Brüne, B. (2013) · International Journal of Cancer · doi:10.1002/ijc.28181 · Cited by 24
Herwartz, C., Castillo-Juárez, P., Schröder, L., Barrón, B. L., & Steger, G. (2015) · Mediators of Inflammation · doi:10.1155/2015/804264 · Cited by 24
Anabolic actions of PTH in murine models: two decades of insights
Zweifler, L. E., Koh, A. J., Daignault‐Newton, S., & McCauley, L. K. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4389 · Cited by 22
Kim, Y. S., Jo, D., Lee, H., Kim, J. H., Kim, K.-W., & Kim, J. H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.045 · Cited by 22
Gui, D., LI, Y., CHEN, X., Gao, D.-W., Yang, Y., & Li, X. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2859 · Cited by 21
Yuan, Q., Arkudas, A., Horch, R. E., Hammon, M., Bleiziffer, O., Uder, M., & Seuß, H. (2017) · Tissue Engineering Part A · doi:10.1089/ten.tea.2017.0262 · Cited by 21
Saha (2009) · International Journal of Oncology · doi:10.3892/ijo_00000231 · Cited by 20
Zuloaga, K. L., & Gonzales, R. J. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00446.2011 · Cited by 20
Anti-angiogenic potential of an ethanol extract of Annona atemoya seeds in vitro and in vivo
Yi, J.-M., Park, J.-S., Lee, J. H., Hong, J. T., Bang, O., & Kim, N. S. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-353 · Cited by 19
Eicosanoids and other lipid mediators and the tumor hypoxic microenvironment
Krishnamoorthy, S., & Honn, K. V. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9309-9 · Cited by 19
Kato, M., Yamamoto, S., Takano, M., Matsubara, O., & Furuya, K. (2012) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e318237d66c · Cited by 19
Thapa, D., Kang, Y., Park, P., Noh, S. K., Lee, Y. R., Han, S. S., Ku, S., Jung, Y., & Kim, J. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.35.924 · Cited by 19
Choudhary, R., Malairaman, U., & Katyal, A. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.07.015 · Cited by 19
Enhancing the Efficacy of Adoptive Cellular Therapy By Targeting Tumor-InDuced Immunosuppression
Beavis, P. A., Slaney, C. Y., Kershaw, M. H., Neeson, P. J., & Darcy, P. K. (2015) · Immunotherapy · doi:10.2217/imt.15.16 · Cited by 18
Expression and association of carbonic anhydrase IX and cyclooxygenase-2 in colorectal cancer
Tupá, V., Drahošová, S., Grendár, M., & Adamkov, M. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.01.012 · Cited by 19
Guo, C.-H., Hsia, S., Chung, C.-H., Lin, Y., Shih, M.-Y., Chen, P., Hsu, G. W., Fan, C.-T., & Peng, C.-L. (2021) · Marine Drugs · doi:10.3390/md19040193 · Cited by 18
Stoyanoff, T. R., Rodríguez, J. P., Todaro, J. S., Espada, J. D., Colavita, J. P. M., Brandan, N. C., Torres, A. M., & Aguirre, M. V. (2016) · Tumor Biology · doi:10.1007/s13277-016-5279-4 · Cited by 18
The Multifaceted Role of Hypoxia‐Inducible Factor 1 (HIF1) in Lipid Metabolism
Shen, G., & Li, X. (2017) · InTech eBooks · doi:10.5772/65340 · Cited by 18
A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells
Jalota, A., Kumar, M., Das, B. C., Yadav, A. K., Chosdol, K., & Sinha, S. (2018) · Oncotarget · doi:10.18632/oncotarget.24839 · Cited by 20
Role and Regulation of Mechanotransductive HIF-1α Stabilisation in Periodontal Ligament Fibroblasts
Kirschneck, C., Thuy, M., Leikam, A., Beisel-Memmert, S., Deschner, J., Damanaki, A., Spanier, G., Proff, P., Jantsch, J., & Schröder, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249530 · Cited by 18
Metadata
- Authors
- Kaidi, A., Qualtrough, D., Williams, A. C., & Paraskeva, C.
- Affiliations
- Cancer Research UK (GB)
- Venue
- Cancer Research
- Published
- 2006-07-01
- Volume
- 66
- Issue
- 13
- Pages
- 6683-6691
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2008854828
- Cited by
- 300
- References
- 49
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 10 · 2023: 6 · 2022: 13 · 2021: 17 · 2020: 24 · 2019: 18 · 2018: 13 · 2017: 16 · 2016: 17 · 2015: 23 · 2014: 16 · 2013: 19 · 2012: 22
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- Explore Bristol Research (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- cyclooxygenase-2, hypoxia-inducible factor-1α, colorectal cancer, colorectal adenoma, hypoxia, prostaglandin E2, hypoxia response element, transcriptional regulation, vascular endothelial growth factor, MAPK signaling, tumor cell survival, angiogenesis, COX-2 selective inhibitors, tumor microenvironment
- MeSH terms
- Base Sequence, Cell Survival, Humans, Molecular Sequence Data, Promoter Regions, Genetic, Transcription, Genetic, Colorectal Neoplasms, Dinoprostone, Cell Hypoxia, Up-Regulation, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, HT29 Cells, MAP Kinase Signaling System, HCT116 Cells, Cell Growth Processes, Cyclooxygenase 2, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review